[HTML][HTML] The great potential of flavonoids as candidate drugs for NAFLD
L Li, Y Qin, X Xin, S Wang, Z Liu, X Feng - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of approximately 25%
and is associated with high morbidity and high mortality. NAFLD is a leading cause of …
and is associated with high morbidity and high mortality. NAFLD is a leading cause of …
The great potential of flavonoids as candidate drugs for NAFLD.
L Li, Y Qin, X Xin, S Wang, Z Liu, X Feng - 2023 - cabidigitallibrary.org
Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of approximately 25%
and is associated with high morbidity and high mortality. NAFLD is a leading cause of …
and is associated with high morbidity and high mortality. NAFLD is a leading cause of …
The great potential of flavonoids as candidate drugs for NAFLD
L Li, Y Qin, X Xin, S Wang, Z Liu… - Biomedicine & …, 2023 - pubmed.ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of approximately 25%
and is associated with high morbidity and high mortality. NAFLD is a leading cause of …
and is associated with high morbidity and high mortality. NAFLD is a leading cause of …
The great potential of flavonoids as candidate drugs for NAFLD.
L Li, Y Qin, X Xin, S Wang, Z Liu… - Biomedicine & …, 2023 - europepmc.org
Non-alcoholic fatty liver disease (NAFLD) has a global prevalence of approximately 25%
and is associated with high morbidity and high mortality. NAFLD is a leading cause of …
and is associated with high morbidity and high mortality. NAFLD is a leading cause of …